Chengguo Xing

5.4k total citations · 1 hit paper
116 papers, 4.4k citations indexed

About

Chengguo Xing is a scholar working on Molecular Biology, Complementary and alternative medicine and Plant Science. According to data from OpenAlex, Chengguo Xing has authored 116 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 30 papers in Complementary and alternative medicine and 26 papers in Plant Science. Recurrent topics in Chengguo Xing's work include Medicinal Plant Extracts Effects (29 papers), Cell death mechanisms and regulation (15 papers) and Plant chemical constituents analysis (14 papers). Chengguo Xing is often cited by papers focused on Medicinal Plant Extracts Effects (29 papers), Cell death mechanisms and regulation (15 papers) and Plant chemical constituents analysis (14 papers). Chengguo Xing collaborates with scholars based in United States, China and South Korea. Chengguo Xing's co-authors include Chunlin Zhuang, Wannian Zhang, Zhenyuan Miao, Chunquan Sheng, Wen Zhang, Balasubramanian Srinivasan, Junxuan Lü, Jignesh Doshi, Defeng Tian and Sreekanth C. Narayanapillai and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Chengguo Xing

113 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chalcone: A Privileged Structure in Medicinal Chemistry

2017 1.1k citations Chunlin Zhuang, Wen Zhang et al. Chemical Reviews profile →

Peers

Countries citing papers authored by Chengguo Xing

Since Specialization

Citations

This map shows the geographic impact of Chengguo Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengguo Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengguo Xing more than expected).

Fields of papers citing papers by Chengguo Xing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengguo Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengguo Xing. The network helps show where Chengguo Xing may publish in the future.

Co-authorship network of co-authors of Chengguo Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Chengguo Xing. A scholar is included among the top collaborators of Chengguo Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengguo Xing. Chengguo Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trial 2024 ·BMC Complementary Medicine and Therapies ·Chengguo Xing, John Malaty, (unknown), Frank A. Orlando, Allison M. Lynch, Zhiguang Huo, (unknown), Roberto Firpi-Morell, Carla L. Fisher, Demetra D. Christou, Ramzi G. Salloum	0
2	Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis 2023 ·Nutrients ·(unknown), (unknown), Jianqiang Yu, Chengguo Xing, Chunlin Zhuang, Zhuo Qu	11
3	Opportunities and Challenges of Kava in Lung Cancer Prevention 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Tengfei Bian, K. Ballas, Allison M. Lynch, (unknown), Zhiguang Huo, Kristianna M. Fredenburg, Adriaan W. Bruijnzeel, Carolyn J. Baglole, Junxuan Lü, Ramzi G. Salloum, John Malaty, Chengguo Xing	7
4	Diallyl disulfide blocks cigarette carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis via activation of Nrf2 antioxidant system and suppression of NF-κB inflammatory response 2023 ·SSRN Electronic Journal ·(unknown), Wenli Zhao, (unknown), Ying Shi, Jianqiang Yu, Wannian Zhang, Chengguo Xing, Chunlin Zhuang, Zhuo Qu	1
5	Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava 2023 ·Trials ·Chengguo Xing, John Malaty, (unknown), (unknown), (unknown), Zhiguang Huo, (unknown), Ramzi G. Salloum	1
6	Implementation strategies for integrating tobacco cessation treatment in cancer care: A qualitative study 2022 ·SHILAP Revista de lepidopterología ·Jennifer H. LeLaurin, Ryan P. Theis, Jesse Dallery, Natalie L. Silver, Merry Jennifer Markham, Stephanie A. S. Staras, Chengguo Xing, Elizabeth Shenkman, Graham Warren, Ramzi G. Salloum	1
7	Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers 2022 ·Journal of Ethnopharmacology ·Raju S. Kanumuri, (unknown), (unknown), Christopher R. McCurdy, Carol A. Mathews, Chengguo Xing, Abhisheak Sharma	8
8	Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease 2022 ·ACS Chemical Neuroscience ·Wenli Zhao, Yue Liu, Lijuan Xu, Yuan He, Zhenyu Cai, Jianqiang Yu, Wannian Zhang, Chengguo Xing, Chunlin Zhuang, Zhuo Qu	18
9	The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers 2020 ·Cancer Prevention Research ·Yi Wang, Sreekanth C. Narayanapillai, Katelyn Tessier, Lori Strayer, Pramod Upadhyaya, Qi Hu, (unknown), Ramzi G. Salloum, Junxuan Lü, Stephen S. Hecht, Dorothy K. Hatsukami, Naomi Fujioka, Chengguo Xing	14
10	Chalcone: A Privileged Structure in Medicinal Chemistry breakdown → 2017 ·Chemical Reviews ·Chunlin Zhuang, Wen Zhang, Chunquan Sheng, Wannian Zhang, Chengguo Xing, Zhenyuan Miao	1105
11	Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis 2015 ·Cancer Prevention Research ·(unknown), Jinhui Zhang, Wei Wu, Peixin Jiang, (unknown), Yong Zhang, Chengguo Xing, Sung‐Hoon Kim, Cheng Jiang, Junxuan Lü	19
12	Kava Blocks 4-(Methylnitrosamino)-1-(3-pyridyl)-1-Butanone–Induced Lung Tumorigenesis in Association with Reducing O6 -methylguanine DNA Adduct in A/J Mice 2014 ·Cancer Prevention Research ·(unknown), Sreekanth C. Narayanapillai, Silvia Balbo, Bo Zhou, Pramod Upadhyaya, Ahmad Ali Shaik, Maeve O’Sullivan, Stephen S. Hecht, Junxuan Lü, Chengguo Xing	31
13	After Embedding in Membranes Antiapoptotic Bcl-XL Protein Binds Both Bcl-2 Homology Region 3 and Helix 1 of Proapoptotic Bax Protein to Inhibit Apoptotic Mitochondrial Permeabilization 2014 ·Journal of Biological Chemistry ·Jingzhen Ding, Blaine H. M. Mooers, Zhi Zhang, Justin Kale, (unknown), (unknown), Bo Huang, Xuejun C. Zhang, Chengguo Xing, David W. Andrews, Jialing Lin	65
14	Overexpression of Mcl-1 Confers Multidrug Resistance, Whereas Topoisomerase IIβ Downregulation Introduces Mitoxantrone-Specific Drug Resistance in Acute Myeloid Leukemia 2013 ·Molecular Pharmacology ·David Hermanson, (unknown), Yunfang Li, Chengguo Xing	37
15	Mouse Prostate Proteome Changes Induced by Oral Pentagalloylglucose Treatment Suggest Targets for Cancer Chemoprevention 2011 ·Current Cancer Drug Targets ·(unknown), Katai J. Nkhata, (unknown), (unknown), (unknown), Yan Zhang, L. A. Higgins, Kwan‐Hyun Kim, (unknown), Chengguo Xing, Sung‐Hoon Kim, Junxuan Lü	9
16	Chalcone-based inhibitors against hypoxia-inducible factor 1—Structure activity relationship studies 2010 ·Bioorganic & Medicinal Chemistry Letters ·Balasubramanian Srinivasan, Thomas E. Johnson, Chengguo Xing	18
17	Dual Mechanisms of sHA 14-1 in Inducing Cell Death through Endoplasmic Reticulum and Mitochondria 2009 ·Molecular Pharmacology ·David Hermanson, Sadiya N. Addo, Anna Bajer, Jonathan S. Marchant, (unknown), Balasubramanian Srinivasan, (unknown), Francesco Michelangeli, David D. Thomas, Tucker W. LeBien, Chengguo Xing	43
18	Biomarkers identification and detection based on GMR sensor and sub 13 nm magnetic nanoparticles 2009 ·PubMed ·Yuanpeng Li, Ying Jing, Xiaofeng Yao, Balasubramanian Srinivasan, Yunhao Xu, Chengguo Xing, Jian‐Ping Wang	4
19	Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[ a ]pyrene–Induced Lung Tumorigenesis in A/J Mice 2008 ·Cancer Prevention Research ·Thomas E. Johnson, Fekadu Kassie, Maeve O’Sullivan, (unknown), Timothy Hanson, Pramod Upadhyaya, Peter P. Ruvolo, Stephen S. Hecht, Chengguo Xing	36
20	WL-276, an Antagonist against Bcl-2 Proteins, Overcomes Drug Resistance and Suppresses Prostate Tumor Growth 2008 ·Cancer Research ·(unknown), Daniel T. Sloper, Sadiya N. Addo, Defeng Tian, Joel W. Slaton, Chengguo Xing	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact